Daiwa Securities Group Inc. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 237 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$40.0%6920.0%0.00%
Q1 2024$40.0%6920.0%0.00%
Q4 2023$4
-20.0%
6920.0%0.00%
Q3 2023$50.0%6920.0%0.00%
Q2 2023$5
-16.7%
6920.0%0.00%
Q1 2023$6
-25.0%
6920.0%0.00%
Q4 2022$8
-99.9%
6920.0%0.00%
Q3 2022$9,000
+28.6%
6920.0%0.00%
Q2 2022$7,000
-22.2%
692
+31.8%
0.00%
Q1 2022$9,000
+28.6%
5250.0%0.00%
Q4 2021$7,000
-22.2%
525
-14.4%
0.00%
Q3 2021$9,000
+80.0%
613
+84.6%
0.00%
Q2 2021$5,000
+66.7%
3320.0%0.00%
Q1 2021$3,000
+50.0%
3320.0%0.00%
Q4 2020$2,000
-33.3%
332
-66.3%
0.00%
Q3 2020$3,000
+50.0%
986
+13.5%
0.00%
Q2 2020$2,0000.0%8690.0%0.00%
Q1 2020$2,000
-33.3%
8690.0%0.00%
Q4 2019$3,000
+50.0%
869
+24.7%
0.00%
Q3 2019$2,000
-33.3%
6970.0%0.00%
Q2 2019$3,000
-50.0%
6970.0%0.00%
Q1 2019$6,000
+50.0%
697
+28.1%
0.00%
Q4 2018$4,0000.0%5440.0%0.00%
Q3 2018$4,000
+33.3%
5440.0%0.00%
Q2 2018$3,0000.0%5440.0%0.00%
Q1 2018$3,0005440.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders